Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients

Ibrutinib is an oral first-in-class Bruton’s tyrosine kinase inhibitor approved for the therapy of various B-cell lymphoid malignancies. Among ibrutinib-related infections, viral hepatitis are poorly described. We report our single-center experience with 4 cases of chronic hepatitis E virus infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Protin, Caroline, Abravanel, Florence, Alric, Laurent, Tavitian, Suzanne, Obéric, Lucie, Izopet, Jacques, Martin-Blondel, Guillaume, Ysebaert, Loic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798245/
https://www.ncbi.nlm.nih.gov/pubmed/31660412
http://dx.doi.org/10.1093/ofid/ofz345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798245/
https://www.ncbi.nlm.nih.gov/pubmed/31660412
http://dx.doi.org/10.1093/ofid/ofz345

Ejemplares similares